CelLBxHealth (FRA:DWV) Net Margin %: -1,846.69% (As of Dec. 2025)


What is CelLBxHealth Net Margin %?

CelLBxHealth FRA:DWV -8.11% Net Margin % is -1,846.69% as of Dec. 2025. The stock has 5 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, CelLBxHealth ranks worse than 94.61% on this metric.

Net margin is calculated as Net Income divided by its Revenue. CelLBxHealth's Net Income for the six months ended in Dec. 2025 was €-11.71 Mil. CelLBxHealth's Revenue for the six months ended in Dec. 2025 was €0.63 Mil. Therefore, CelLBxHealth's net margin for the quarter that ended in Dec. 2025 was -1,846.69%.

The historical rank and industry rank for CelLBxHealth's Net Margin % or its related term are showing as below:

FRA:DWV' s Net Margin % Range Over the Past 10 Years
Min: -2083.19   Med: -1337.14   Max: -497.03
Current: -1444.04

FRA:DWV's Net Margin % is ranked worse than
94.61% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -2.405 vs FRA:DWV: -1444.04

CelLBxHealth  (FRA:DWV) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

CelLBxHealth Net Margin % Related Terms

CelLBxHealth Net Margin % Historical Data

* Premium members only.

The historical data trend for CelLBxHealth's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CelLBxHealth Net Margin % Chart

CelLBxHealth Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,482.13 -2,083.12 -921.09 -497.08 -1,443.56

CelLBxHealth Semi-Annual Data
Apr16 Oct16 Apr17 Oct17 Apr18 Oct18 Apr19 Oct19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,042.47 -745.99 -356.23 -1,164.85 -1,846.69

FRA:DWV vs TMO, DHR, IDXX: Net Margin % Comparison

For the Diagnostics & Research subindustry, CelLBxHealth's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CelLBxHealth Net Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, CelLBxHealth's Net Margin % distribution charts can be found below:

* The bar in red indicates where CelLBxHealth's Net Margin % falls into.


CelLBxHealth Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

CelLBxHealth's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-22.303/1.545
=-1,443.56 %

CelLBxHealth's Net Margin for the quarter that ended in Dec. 2025 is calculated as

Net Margin=Net Income (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-11.708/0.634
=-1,846.69 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of -1,846.69% mean?
CelLBxHealth (FRA:DWV) has a Net Margin % of -1,846.69% as of Dec. 2025. Net margin is the ratio of total net income to net sales. View historical data on CelLBxHealth and its competitors. According to the industry distribution chart, CelLBxHealth ranks #193 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 94.6%.
Is CelLBxHealth's Net Margin % too high?
CelLBxHealth's current Net Margin % is -1,846.69%. Based on the distribution chart, CelLBxHealth ranks #193 out of 204 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does CelLBxHealth's Net Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, CelLBxHealth ranks #193 out of 204 companies for Net Margin %. This places CelLBxHealth in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Diagnostics & Research company?
A good Net Margin % depends on the Medical Diagnostics & Research industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on CelLBxHealth and its competitors. CelLBxHealth's current Net Margin % is -1,846.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CelLBxHealth stock overvalued right now?
CelLBxHealth (FRA:DWV) has a current Net Margin % of -1,846.69%. The current Net Margin % is -1,846.69%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For CelLBxHealth (FRA:DWV), the current Net Margin % is -1,846.69% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CelLBxHealth Business Description

Other Exchanges ANPCF:USACLBX:UK
Address 10 Nugent Road, The Surrey Research Park, Surrey, Guildford, GBR, GU2 7AF
CelLBxHealth PLC is active in the healthcare sector in the United Kingdom. The Company's principal trading activity is undertaken in relation to the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy that is non-invasive cancer diagnostics. It is a medical diagnostic company specializing in the development of pioneering products in cancer diagnostics. Its patented Parsortix technology can potentially treat and diagnose various forms of cancer. The Parsortix system can capture and harvest CTCs from patient blood. Its geographical segments include Europe and North America, of which the majority of its revenue is generated from Europe.